Kenson Ventures is a Palo Alto, California-based venture capital firm founded in 1999 that provides seed and early-stage. See sector focus and contact routes.
Kenson Ventures is a Palo Alto, California-based venture capital firm founded in 1999 that provides seed and early-stage funding alongside strategic advice to emerging companies. The firm’s investment thesis centers on biotechnology and life sciences, specifically targeting sectors such as diagnostics, drug development, and research tools, with a primary geographic focus on private companies in the United States. Typical investment checks range from $500,000 to $3 million, and the firm often participates as a co-investor alongside other institutions rather than exclusively leading rounds. While Kenson Ventures does not publish a detailed public portfolio list on its website, it is notably recognized for founding Clontech, a major genetic tool company, and has supported entrepreneurs across medical diagnostics and drug development. The firm’s distinctive point of view emphasizes fostering thriving enterprises through expert strategic guidance to advance basic and drug discovery research for improved healthcare outcomes. Founder and chairman Dr. Kenneth Fong has led the firm for over two decades, during which numerous companies have been acquired or g
Every field above is read from the StartupFundraising firm directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with comparable investors when building a target list.
Investors like Kenson Ventures · Full investor directory · Investor access · Company funding database